Pet Healthcare North America (NAFTA) Industry Guide 2020-2029
Description
Pet Healthcare North America (NAFTA) Industry Guide 2020-2029
Summary
The NAFTA Pet Healthcare industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume , and forecast to 2029). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
Summary
The NAFTA Pet Healthcare industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume , and forecast to 2029). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The North American Free Trade Agreement (NAFTA) is a trade agreement between the countries in North America: the US, Canada and Mexico. The pet healthcare industry within the NAFTA countries had a total market value of $14,643.1 million in 2024.The Mexico was the fastest growing country, with a CAGR of 7.3% over the 2020-24 period.
- Within the pet healthcare industry, the US is the leading country among the NAFTA bloc, with market revenues of $12,929.7 million in 2024. This was followed by Mexico and Canada, with a value of $991.1 and $722.2 million, respectively.
- The US is expected to lead the pet healthcare industry in the NAFTA bloc, with a value of $14,526.5 million in 2029, followed by Mexico and Canada with expected values of $1,372.2 and $817.6 million, respectively.
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the NAFTA pet healthcare market
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the NAFTA pet healthcare market
- Leading company profiles reveal details of key pet healthcare market players’ NAFTA operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the NAFTA pet healthcare market with five year forecasts by both value and volume
- Compares data from the US, Canada and Mexico, alongside individual chapters on each country
- What was the size of the NAFTA pet healthcare market by value in 2024?
- What will be the size of the NAFTA pet healthcare market in 2029?
- What factors are affecting the strength of competition in the NAFTA pet healthcare market?
- How has the market performed over the last five years?
- Who are the top competitors in the NAFTA pet healthcare market?
Table of Contents
133 Pages
- 1 Introduction
- 1.1. What is this report about?
- 1.2. Who is the target reader?
- 1.3. How to use this report
- 1.4. Definitions
- 2 NAFTA Pet Healthcare
- 2.1. Industry Outlook
- 3 Pet Healthcare in Canada
- 3.1. Market Overview
- 3.2. Market Data
- 3.3. Market Segmentation
- 3.4. Market outlook
- 3.5. Five forces analysis
- 4 Macroeconomic Indicators
- 4.1. Country data
- 5 Pet Healthcare in Mexico
- 5.1. Market Overview
- 5.2. Market Data
- 5.3. Market Segmentation
- 5.4. Market outlook
- 5.5. Five forces analysis
- 6 Macroeconomic Indicators
- 6.1. Country data
- 7 Pet Healthcare in The United States
- 7.1. Market Overview
- 7.2. Market Data
- 7.3. Market Segmentation
- 7.4. Market outlook
- 7.5. Five forces analysis
- 8 Macroeconomic Indicators
- 8.1. Country data
- 9 Company Profiles
- 9.1. Elanco Animal Health Inc
- 9.2. Boehringer Ingelheim International GmbH
- 9.3. Unicharm Corp
- 9.4. Nutramax Laboratories Inc
- 9.5. Zoetis Inc
- 9.6. Virbac SA
- 9.7. Beaphar BV
- 9.8. Perrigo Company
- 9.9. Trixie Heimtierbedarf GmbH & Co KG
- 9.10. H. von Gimborn GmbH
- 9.11. Sera GmbH
- 9.12. Vetalogica Australia Pty Ltd
- 9.13. Vetafarm Australia Pty Ltd
- 9.14. Total Quimica Industria E Comercio Ltda
- 9.15. Hypera SA
- 9.16. Compana Pet Brands LLC
- 9.17. Omega Alpha Pharmaceuticals
- 9.18. Pet Smile LLC
- 9.19. Shenzhen Hongrui Biological Technology Co Ltd
- 9.20. Himalaya Global Holdings Ltd
- 9.21. Cargill Inc
- 9.22. Soparfin SCA
- 9.23. To Doggy With Love LLC
- 9.24. Mind Up Co Ltd
- 9.25. Kordon LLC
- 9.26. Sanofi-Aventis Groupe SA
- 9.27. Fibro Pharmaceutical Co Ltd
- 9.28. Fujita Pharmaceutical Co.,Ltd.
- 9.29. Riverfarma SA de CV
- 9.30. PetIQ Inc
- 9.31. Kala Health Inc
- 9.32. Kit Cat International Pte Ltd
- 9.33. Nutri-Pet Research Inc
- 9.34. Ascendis Health Ltd
- 9.35. Pets Choice Ltd
- 9.36. Marltons Pets and Products
- 9.37. Kyron Laboratories Pty Ltd
- 9.38. Rolf C. Hagen Inc
- 9.39. Cunipic Animals de Compania SL
- 9.40. Ceva Sante Animale
- 9.41. Multifit Tiernahrungs GmbH
- 9.42. Bogar AG
- 9.43. Biogance Sarl
- 9.44. Specht Biopharma
- 9.45. Dr.Clauder solutions for Pets GmbH
- 9.46. Johnsons Veterinary Products Ltd
- 9.47. Nextmune AB
- 10 Appendix
- 10.1. Methodology
- 10.2. About MarketLine
- List of Tables
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

